AARDVARK THERAPEUTICS, INC. Diluted Shares Outstanding (Weighted Average)
AARDVARK THERAPEUTICS, INC. (AARD) reported Diluted Shares Outstanding (Weighted Average) of 21.85 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-11
- AARDVARK THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 21.85M shares, a 0.72% increase year-over-year.
- AARDVARK THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 21.82M shares, a 65.34% increase year-over-year.
- AARDVARK THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 21.81M shares, a 436.69% increase year-over-year.
- AARDVARK THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 21.71M shares, a 444.62% increase year-over-year.
- AARDVARK THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 19.62M shares, a 391.06% increase from fiscal 2024.
- AARDVARK THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 4.00M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 21.85M shares 10-Q · filed 2026-08-11 | 21.83M shares 10-Q · filed 2026-08-11 | 21.82M shares derived: average of 3 quarters · filed 2026-08-11 | 21.80M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 21.82M shares 10-Q · filed 2026-05-07 | 21.81M shares derived: average of 2 quarters · filed 2026-05-07 | 21.78M shares derived: average of 3 quarters · filed 2026-05-07 | 21.76M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 21.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 21.76M shares derived: average of 2 quarters · filed 2026-03-23 | 21.74M shares derived: average of 3 quarters · filed 2026-08-11 | 19.62M shares 10-K · filed 2026-03-23 |
| 2025-09-30 | 21.71M shares 10-Q · filed 2025-11-13 | 21.70M shares derived: average of 2 quarters · filed 2026-08-11 | 18.90M shares 10-Q · filed 2025-11-13 | 15.17M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 21.69M shares 10-Q · filed 2026-08-11 | 17.47M shares 10-Q · filed 2026-08-11 | 12.98M shares derived: average of 3 quarters · filed 2026-08-11 | 10.73M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 13.19M shares 10-Q · filed 2026-05-07 | 8.63M shares derived: average of 2 quarters · filed 2026-05-07 | 7.08M shares derived: average of 3 quarters · filed 2026-05-07 | 6.30M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 4.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 4.03M shares derived: average of 2 quarters · filed 2026-03-23 | 4.01M shares derived: average of 3 quarters · filed 2026-03-23 | 4.00M shares 10-K · filed 2026-03-23 |
| 2024-09-30 | 3.99M shares 10-Q · filed 2025-11-13 | 3.98M shares derived: average of 2 quarters · filed 2025-11-13 | 3.97M shares 10-Q · filed 2025-11-13 | |
| 2024-06-30 | 3.97M shares 10-Q · filed 2025-08-13 | 3.97M shares 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | 3.97M shares 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |